![[TXT]](/icons/text.gif) 121a.0907-1 Novel and Conventional biomarkers for prediction of incident CV events in the community (Melander, jama).pdf | 391.33Kb | July 2 2009 |
| 121a.0907-2 Biomarkers and CVD. Determining causality & quantifying contribution to risk assessment (Shah, jama) Edito.pdf | 300.69Kb | July 2 2009 |
| 122.0906Epub-Prevalence of Polyvascular disease in patients referred for PAD (Vidakovic, ejves).pdf | 383.06Kb | July 2 2009 |
| 133.0906-Exercise training for T2 diabetes, Impact on CV risk (AHA Marwick, Circulation).pdf | 502.19Kb | July 2 2009 |
| 134.0906-Benefits of statins in people without established CVD but with CV-RF. MA (Brugts, bmj).pdf | 597.77Kb | July 2 2009 |
| 135.0906-Mortality, Health outcomes and BMI in the overweight range. AHA (Lewis, Circulation).pdf | 438.67Kb | July 2 2009 |
| 138.0906-Kidney function and risk of CVD and mortality in women. Prospective cohort study (Kurth, bmj).pdf | 576.98Kb | July 2 2009 |
| 212.0907-Rôle du tabagisme dans la pathologie vasculaire cérébrale (Girot, Press Med).pdf | 310.44Kb | July 2 2009 |
| 255.0907-Patches for carotid endarterectomy. Currents materials and prospects (Muto, jvs).pdf | 291.97Kb | July 2 2009 |
| 258sf.0907-There is no sex equality in carotid disease. Letter (Naylor, jvs).pdf | 231.02Kb | July 2 2009 |
| 310.0907-Metabolic Sdr and vascular risk in patients with PAOD (Vlek, jvs).pdf | 505.04Kb | July 2 2009 |
| 311.0907-Five year results of the getABI study (Forbes, jvs).pdf | 218.24Kb | July 2 2009 |
| 312q.0907-WIQ, an effective tool to assess the effect of Tt in patients with IC (Nicolaï, jvs).pdf | 313.19Kb | July 2 2009 |
| 316.0907-Sex differences in calf muscle HbO2 saturation in patients with IC (Gardner, jvs).pdf | 284.64Kb | July 2 2009 |
| 350.0907-Prevalence of atherosclerotic RAS in risk groups. Systematic literature review (de Mast, J Hypert).pdf | 381.83Kb | July 2 2009 |
| 351.0907-US velocity criteria for renal in-stent restenosis (Chi, jvs).pdf | 407.83Kb | July 2 2009 |
| 363.0907-Physiopathologie des anévrysmes idiopathiques de l'aorte thoracique ascendante (Costin Radu, Press Med).pdf | 504.90Kb | July 2 2009 |
| 371.0907-Evidence from cross-sectionnal imaging indicates AAA but not TAA are local manifestations of a systemic dilating diathesis (Nordon, jvs).pdf | 662.54Kb | July 2 2009 |
| 377s.0906-Durability of EVAR, When does late failure occurs and why (Chuter, Ann Vasc Surg).pdf | 1.07Mb | July 2 2009 |
| 377s.0906-Fate of proximal aorta following open infrarenal AAA repair (Cao, Ann Vasc Surg).pdf | 332.49Kb | July 2 2009 |
| 381.0907-Evidence from cross-sectionnal imaging indicates AAA but not TAA are local manifestations of a systemic dilating diathesis (Nordon, jvs).pdf | 662.57Kb | July 2 2009 |
| 460.0907-Celiac artery compression Sdr managed by laparoscopy (Baccari, jvs).pdf | 579.19Kb | July 2 2009 |
| 600.0904-Unanswered questions in VTE (Wietz, Thromb Research).pdf | 297.35Kb | July 2 2009 |
| 610.0904-Effects of race and ethnicity on the incidence of VTE (White, Thromb Research).pdf | 534.56Kb | July 2 2009 |
| 620.0907-VTE prophylaxis. Quality, location (hospital vs home), duration (Goldhaber, TH).pdf | 225.90Kb | July 2 2009 |
| 622.0809-The surgeons general's call to action to prevent DVT and PE.pdf | 870.73Kb | July 2 2009 |
| 622kc.0907-Lack of extended VTE prophylaxis in HR patients undergoing major orthopaedic or cancer surgery (Kalka, TH).pdf | 282.39Kb | July 2 2009 |
| 622ot.0907-Lack of extended VTE prophylaxis in HR patients undergoing major orthopaedic or cancer surgery (Kalka, TH).pdf | 282.39Kb | July 2 2009 |
| 631.0904-Pathophysiology of venous thrombosis (Lopez, Thromb Research).pdf | 275.12Kb | July 2 2009 |
| 634a.0907-1 Accuracy of a complete CUS in ruling out suspected DVT in the ambulatory setting (Sevestre, TH). OPTIMEV.pdf | 517.79Kb | June 29 2009 |
![[DIR]](/icons/back.gif){kind=icon}
Parent Directory